Metraipolis › archive › dc_cbe7471d99ca

Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study — Europe PMC PMID:42460324

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42460324
DOI
10.3389/fendo.2026.1885961
License (as archived)
solo-consultazione
Archived
2026-10-18T13:51:36.922Z
SHA-256 of the archived text
7ac7fe4cf49d5f16f6f9fa054786128fe77d33b3504c82f7b72d22a822c0942d
Stable URL of this page
https://metraipolis.com/documento/dc_cbe7471d99ca

How to cite

Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study — Europe PMC PMID:42460324 — Europe PMC (en), https://europepmc.org/article/MED/42460324 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cbe7471d99ca (Metraipolis archive dc_cbe7471d99ca, sha256 7ac7fe4cf49d5f16f6f9fa054786128fe77d33b3504c82f7b72d22a822c0942d)
BibTeX
@misc{dccbe7471d99ca,
  title = {Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study — Europe PMC PMID:42460324},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42460324},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cbe7471d99ca; sha256 7ac7fe4cf49d5f16f6f9fa054786128fe77d33b3504c82f7b72d22a822c0942d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42460324. Agents can read the archived copy with the MCP tool read_document.